Cargando…
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial
IMPORTANCE: Proliferative verrucous leukoplakia (PVL) is an aggressive oral precancerous disease characterized by a high risk of transformation to invasive oral squamous cell carcinoma (OSCC), and no therapies have been shown to affect its natural history. A recent study of the PVL immune landscape...
Autores principales: | Hanna, Glenn J., Villa, Alessandro, Nandi, Shuvro P., Shi, Ruichao, ONeill, Anne, Liu, Mofei, Quinn, Charles T., Treister, Nathaniel S., Sroussi, Herve Y., Vacharotayangul, Piamkamon, Goguen, Laura A., Annino, Donald J., Rettig, Eleni M., Jo, Vickie Y., Wong, Kristine S., Lizotte, Patrick, Paweletz, Cloud P., Uppaluri, Ravindra, Haddad, Robert I., Cohen, Ezra E. W., Alexandrov, Ludmil B., William, William N., Lippman, Scott M., Woo, Sook-bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654930/ https://www.ncbi.nlm.nih.gov/pubmed/37971722 http://dx.doi.org/10.1001/jamaoncol.2023.4853 |
Ejemplares similares
-
Oral lichen planus: comparative efficacy and treatment costs—a systematic review
por: Sandhu, Shaiba, et al.
Publicado: (2022) -
Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider
por: Klein, Brittany A., et al.
Publicado: (2022) -
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
por: Hanna, Glenn J., et al.
Publicado: (2022) -
Virtual planning and 3D‐printed guides for mandibular reconstruction: Factors impacting accuracy
por: Annino, Donald J., et al.
Publicado: (2022) -
Oral manifestations, salivary flow rates and Candida species in Thai HIV-infected patients
por: Lam-ubol, Aroonwan, et al.
Publicado: (2019)